Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 60,599 | 17,379 | N/A |
| Receivables | 6,481 | 6,179 | N/A |
| Inventories | 5,441 | 4,014 | N/A |
| TOTAL | $74,201 | $28,163 | $N/A |
| Non-Current Assets | |||
| PPE Net | 12,207 | 13,460 | N/A |
| Intangibles | 443 | 254 | 0 |
| Other Non-Current Assets | 0 | 1,239 | 0 |
| TOTAL | $12,650 | $14,953 | $N/A |
| Total Assets | $86,851 | $43,116 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 25,036 | 9,601 | 0 |
| Accrued Expenses | 7,195 | 4,402 | N/A |
| TOTAL | $32,952 | $15,350 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 42,603 | 45,507 | N/A |
| Deferred Revenues | 721 | 1,347 | N/A |
| aiOther Non-Current Liabilities | 1,216 | 8,754 | 0 |
| TOTAL | $43,819 | $54,261 | $N/A |
| Total Liabilities | $76,771 | $69,611 | $N/A |
| Shareholders' Equity | |||
| Shares Outstanding, K | 24,975 | N/A | N/A |
| Common Shares | 25 | 12,727 | N/A |
| Retained earnings | -61,376 | -120,093 | N/A |
| Other shareholders' equity | 0 | 42,101 | 0 |
| TOTAL | $10,080 | $-26,495 | $N/A |
| Total Liabilities And Equity | $86,851 | $43,116 | $0 |